Belmora Flanax Tablet, Film Coated
Product Images NDC 47682-037

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Belmora Flanax (NDC 47682-037). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unifirst First Aid Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

237r (237r Belmora Flanax Pain Reliever 40 Label For Pld)

237r (237r  Belmora Flanax Pain Reliever 40 Label For Pld)
Belmora Flanax pain reliever/fever reducer oral film-coated tablets, each containing 220 mg of naproxen sodium. The packaging highlights longer lasting pain relief for minor aches and pains including headache, backache, arthritis, fever, menstrual cramps, toothache, and common cold. The package includes 20 dual packets with 1 tablet per packet, totaling 40 tablets, and is labeled by Unifirst First Aid Corporation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.